Search
Search Results
##search.searchResults.foundPlural##
-
MALARIA AND HIV IN ADULTS: When The Parasite runs into The Virus
2683PDF: 1000HTML: 2265 -
A MULTICENTER EXPERIENCE FROM LEBANON IN CHILDHOOD AND ADOLESCENT ACUTE MYELOID LEUKEMIA:HIGH RATE OF EARLY DEATH IN CHILDHOOD ACUTE PROMYELOCYTIC LEUKEMIA.
2059PDF: 1112HTML: 7689cover letter paper final AML: 213 -
HEMATOLOGICAL ABNORMALITIES BEYOND LYMPHOCYTOSIS DURING INFECTIOUS MONONUCLEOSIS: EPSTEIN-BARR VIRUS-INDUCED THROMBOCYTOPENIA THROMBOCYTOPENIA DURING INFECTIOUS MONONUCLEOSIS
1983HTML: 536PDF: 1196 -
SARS-CoV-2 (COVID-19) and Chronic Myeloid Leukemia (CML): a case report and review of ABL kinase involvement in viral infection CML and COVID-19
3250PDF: 1525HTML: 417 -
CD48 AS A NOVEL EARLY BIOMARKER COMPLEMENTING PROCALCITONIN AND LACTATE FOR PREDICTING BACTEREMIA IN PEDIATRIC FEBRILE NEUTROPENIA: A PROSPECTIVE COHORT STUDY CD48 A NOVEL EARLY BIOMARKER PREDICTING BACTERIEMIA
833PDF: 584HTML: 107 -
Glucocorticoids and antivirals for HBV reactivation in onco-hematologic patients
934PDF: 567HTML: 2187Cover Letter: 189 -
NEW STRATEGIES FOR STEM CELL MOBILIZATION
2400PDF: 855HTML: 2453 -
-
Tacrolimus Associated Posterior Reversible Encephalopathy Syndrome – A Case Series and Review
3538PDF: 1476HTML: 4384CoverLetter: 183Figure1: 194 -
COULD PLASMA GLUCOSE (PG) INCREMENT (PG %) EXPAND THE CLINICAL WEIGHT OF OGTT? PRELIMINARY FINDINGS IN 19 TDT PATIENTS (Β-TDT) WITH NORMAL GLUCOSE TOLERANCE Plasma glucose (PG) increment (PG %) and pancretic β-cell dysfunction in thalassemia
700PDF: 489HTML: 39 -
GROUP-BASED TRAJECTORY MODELING OF PLATELET IN PATIENTS WITH APLASTIC ANEMIA: A STUDY BASED ON THE MIMIC DATABASE
986PDF: 983Suppl. Files: 632HTML: 118 -
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1379PDF: 814HTML: 3117 -
SARS-CoV-2 INFECTED PATIENTS: FROM A HEMATOLOGIST PERSPECTIVE COVID-19 and Hematology
1047PDF: 960HTML: 323 -
Severe Acute Hepatitis B Treated with Entecavir
1522PDF: 783HTML: 2471Figure: 166Title page: 172disclosure: 104 -
INCREASE IN CANDIDA PARAPSILOSIS CANDIDEMIA IN CANCER PATIENTS
1751PDF: 1068HTML: 245 -
TREATMENT OF LOW-BLAST COUNT AML USING HYPOMETHYLATING AGENTS
4306PDF: 1754HTML: 1106 -
How I treat acute and persistent sickle cell pain
1910PDF: 1112HTML: 482 -
TUBERCULOSIS IN HEMATOPOIETIC STEM CELL TRANSPLANT PATIENTS.
2620PDF: 937HTML: 3603 -
CLINICAL AND HEMATOLOGICAL PROFILE OF PATIENTS WITH DENGUE FEVER AT A TERTIARY CARE HOSPITAL – AN OBSERVATIONAL STUDY
4168PDF: 1734HTML: 493Figure 1: Age distribution of Pediatric cases: 212 -
Interstitial pneumonia triggered by H1N1 influenza A virus as the initial presentation of chronic myeloid leukemia
866PDF: 472HTML: 123Suppl. Files: 308 -
As a Rare Site of Invasive Fungal Infection, Chronic Granulomatous Aspergillus Synovitis: A Case Report
1700PDF: 623HTML: 1512Figure 1: MRI demonstrating Aspergillus synovitis: 183Figure 2:MRI demonstrating Aspergillus synovitis: 187 -
THE ROLE OF THE CAROTID DOPPLER EXAMINATION IN THE EVALUATION OF ATHEROSCLEROTIC CHANGES IN BETA THALASSEMIA PATIENTS
2153PDF: 941HTML: 2999Untitled: 206 -
PRACTICAL RECOMMENDATIONS FOR THE MANAGEMENT OF PATIENTS WITH ITP DURING THE COVID-19 PANDEMIC Recommendation for ITP management during COVID
2464PDF: 919HTML: 519 -
THE Co-Occurrence of Jak2/Calr-Positive Myeloproliferative Disorder and Bcr-Abl-Positive Chronic Myelogenous Leukaemia Treated with Combination of Tyrosine Kinase Inhibitors and Ruxolitinib. Dual Myeloid Disorder Treated with Two Drug Association
1047PDF: 1039HTML: 93 -
CHILDREN IN CORONAVIRUSES’ WONDERLAND: WHAT CLINICIANS NEED TO KNOW Corona virus and Children
1409PDF: 926HTML: 320 -
Evaluating the use of meropenem in hematologic patients with febrile neutropenia A retrospective observational single-cohort study
969PDF: 443HTML: 132 -
TUBERCULOSIS IN TROPICAL AREAS AND IMMIGRANTS
3292PDF: 1310HTML: 6187 -
A CRITICAL HISTORY OF CHRONIC MYELOID LEUKEMIA
3225PDF: 1330HTML: 4129







